TE_23587
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1P2_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | PATE2, ACRV1, - |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 365.18 |
| Counts of samples | TCGA_tumor:323; TCGA_normal:0; GTEx:0 |
| TSS | chr11(-):125857523 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_23587.11 | ACRV1 | Chimeric | Non-coding | Non-coding | chr11(-):125672697,125672717,125676359,125676478,125677797,125678018,125678229,125678297,125684840,125685198,125841331,125841394,125857337,125857524 |
| teRNA_23587.12 | - | Intergenic | Non-coding | Non-coding | chr11(-):125824576,125824596,125841331,125841394,125857337,125857524 |
| teRNA_23587.13 | - | Intergenic | Non-coding | Non-coding | chr11(-):125721664,125721684,125841331,125841394,125857337,125857524 |
| teRNA_23587.14 | - | Intergenic | Non-coding | Non-coding | chr11(-):125844576,125844596,125845205,125845404,125857337,125857524 |
| teRNA_23587.15 | - | Intergenic | Non-coding | Non-coding | chr11(-):125845384,125845404,125857337,125857524 |
| teRNA_23587.16 | - | Intergenic | Non-coding | Non-coding | chr11(-):125841374,125841394,125845205,125845404,125857337,125857524 |
| teRNA_23587.17 | - | Intergenic | Non-coding | Non-coding | chr11(-):125844576,125844596,125845212,125845404,125857337,125857524 |
| teRNA_23587.18 | - | Intergenic | Non-coding | Non-coding | chr11(-):125832548,125832568,125841331,125841394,125844480,125844596,125845205,125845404,125857337,125857524 |
| teRNA_23587.19 | - | Intergenic | Non-coding | Non-coding | chr11(-):125824576,125824596,125841331,125841394,125845205,125845404,125857337,125857524 |
| teRNA_23587.20 | - | Intergenic | Non-coding | Non-coding | chr11(-):125824576,125824596,125841331,125841394,125845103,125845404,125857337,125857524 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
